You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chromosome 16p

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Seattle (procedure, drug, biological)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

Chromosome 9 P Minus Syndrome

Recruiting
  • Chromosome 9P Deletion Syndrome
  • +4 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 30, 2021

    MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

    Recruiting
    • Myelodysplastic Syndromes
    • +5 more
    • description of MDS pzatient cohort
    • Brest, France
      Chu Brest
    Oct 27, 2022

    Primary Sjögren Syndrome Trial (68Ga-P16-093)

    Not yet recruiting
    • Primary Sjögren Syndrome
    • (no location specified)
    Sep 19, 2023

    People Who Have Genetic Changes and Features of Autism: Simons

    Recruiting
    • 16P11.2 Deletion Syndrome
    • +184 more
      • New York, New York
      • +1 more
      Jan 6, 2023

      Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

      Active, not recruiting
      • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 2, 2022

      B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

      Recruiting
      • B Acute Lymphoblastic Leukemia
      • +2 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Dec 16, 2022

      Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

      Recruiting
      • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
      • +5 more
      • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
      • Pembrolizumab
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)

      Recruiting
      • Prostate Cancer
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Nov 1, 2022

      Glioma Trial in Beijing (68Ga-P16-093)

      Recruiting
      • Glioma
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Oct 4, 2022

      Blood Tests and Questionnaires in Studying Adherence to

      Recruiting
      • Carcinoma of Unknown Primary
      • +30 more
      • Biospecimen Collection
      • Questionnaire Administration
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 12, 2022

      Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

      Not yet recruiting
      • Preterm Labor
        • (no location specified)
        May 9, 2023

        Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

        Recruiting
        • Oropharyngeal Cancer
        • Squamous Cell Carcinoma of the Oropharynx
        • Surgery
        • +3 more
        • Ann Arbor, Michigan
          University of Michigan Rogel Cancer Center
        May 30, 2023

        Prostate Cancer Trial in Beijing (68Ga-PSMA-617, 68Ga-P16-093)

        Recruiting
        • Prostate Cancer
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Aug 4, 2022

        Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),

        Recruiting
        • Oropharynx Cancer
        • Radiation therapy (5 days for 7 weeks)
        • +2 more
        • Philadelphia, Pennsylvania
          Fox Chase Cancer Center
        Apr 5, 2023

        Breast Cancer Trial in Beijing (Drug: 68Ga-P16-093)

        Recruiting
        • Breast Cancer
        • Drug: 68Ga-P16-093
        • Beijing, China
          Peking Union Medical College Hospital
        Nov 14, 2022

        Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

        Terminated
        Has Results
        • Philadelphia Chromosome Negative
        • +2 more
        • Blinatumomab
        • +11 more
        • Houston, Texas
          M D Anderson Cancer Center
        Nov 3, 2022

        HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

        Recruiting
        • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
        • +11 more
        • NavDx HPV ctDNA Testing
        • +2 more
        • Boston, Massachusetts
        • +1 more
        Jul 6, 2022

        Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-P16-093, 18F-FDG)

        Recruiting
        • Clear Cell Renal Cell Carcinoma
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Jun 21, 2022

        Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,

        Active, not recruiting
        • Squamous Cell Carcinoma of the Head and Neck
        • Squamous Cell Carcinoma, Head and Neck
        • Saint Louis, Missouri
          Washington University School of Medicine
        Jun 21, 2022

        Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

        Recruiting
        • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
        • +28 more
        • San Francisco, California
          University of California, San Francisco
        Dec 16, 2022

        Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

        Not yet recruiting
        • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
        • +15 more
        • Best Practice
        • +9 more
        • Scottsdale, Arizona
          Mayo Clinic in Arizona
        Aug 23, 2022

        ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial

        Recruiting
        • ENSAT Stage I Adrenal Cortex Carcinoma
        • +2 more
        • Ann Arbor, Michigan
        • +3 more
        Dec 13, 2022

        Oropharynx Cancer Trial in Pittsburgh (procedure, other, radiation, drug)

        Recruiting
        • Oropharynx Cancer
        • therapeutic conventional surgery
        • +5 more
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Oct 4, 2022

        Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

        Recruiting
        • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
        • +5 more
        • Medical Chart Review
        • +3 more
        • Scottsdale, Arizona
        • +1 more
        Mar 15, 2022